Pfizer says tests show its COVID-19 vaccine is effective against new, more contagious variant
A new, more transmissible variant of the coronavirus, first discovered in England, is spreading around the U.S. — Texas' first confirmed case was reported in Harris County on Thursday. But new research from Pfizer and the University of Texas Medical Branch in Galveston suggests the Pfizer-BioNTech COVID-19 vaccine can protect against the new B117 strain. The researchers reported Thursday night that lab tests on blood samples from 20 vaccinated people showed their antibodies successfully fended off the new strain of the virus.
The new findings are preliminary and haven't yet been reviewed by outside experts, but "it was a very reassuring finding that at least this mutation, which was one of the ones people are most concerned about, does not seem to be a problem" for the vaccine, Pfizer chief scientific officer Dr. Philip Dormitzer told The Associated Press. Pfizer's coronavirus vaccine, like most of the others in use worldwide, trains the body to recognize and fight off the spike proteins that the coronavirus uses to infect cells.
The NF01Y mutation found in the U.K. and a different strain in South Africa was already expected to be susceptible to the new vaccines. Infectious disease experts are more worried about how the vaccines will work on another mutation, E484K, found in the South African variant. Pfizer said its study found the vaccine effective against 15 more possible mutations, but not yet E584K, which is next on the list to study.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Lab studies show that the E584K mutation, also found in Brazil, "could make people's antibodies less effective at neutralizing the virus," Stat News reports. "The mutation seems to help the virus disguise part of its signature appearance, so the pathogen might have an easier time slipping past immune protection." But even if the vaccines are less effective, they won't be useless, molecular virologist Ramón Lorenzo-Redondo at Northwestern University's Feinberg School of Medicine told Stat News. "With one mutation or even three mutations, it's expected the antibodies will still recognize this variant, though they might not recognize it as well as other variants."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published